BriaCell Therapeutics (TSXV:BCT; OTCQB:BCTXF) appointed immunology expert, Cara Haymaker, to its scientific advisory board, effective immediately. In addition, Dr. Bill Williams, president and CEO, has been selected to...
Online continuing professional development provider, MDBriefCase Group (MDBC), is collaborating with Dr. David Strain, senior clinical lecturer at the University of Exeter and Dr. Mohamed Farghaly, associate professor...
Kimberly Peery Stereotaxis (NYSE American:STXS) appointed Kimberly Peery as CFO, effective October 1, replacing Martin Stammer, who has accepted a position as CFO of a large professional services firm in the St. Louis...
Salarius Pharmaceuticals (NASDAQ:SLRX) has appointed Scott Jordan as chief business officer (CBO) and Mark Rosenblum as EVP finance and interim CFO. Mr. Jordan has been Salarius’ CFO since 2016. As CBO, he will lead...
Neil McFarlane Adamas Pharmaceuticals (NASDAQ:ADMS) has appointed Neil McFarlane as CEO and a member of its board, effective Sept. 16. Gregory Went, Adamas’ founder, chairman and CEO, will transition to a strategic...
Elaine Jones Gritstone Oncology (NASDAQ:GRTS) appointed Elaine Jones as a director, replacing Peter Svennilson, founder of the Column Group and co-lead Series A investor in Gritstone. Dr. Jones was most recently VP...
Closely-held Spartan Bioscience named Blaine Fitzgerald, former VP of finance for Shopify, as CFO. In addition, the company appointed Steve Edgett as EVP to lead its international business development and strategic...
Roth Capital Partners named Zegbeh Jallah as a director and research analyst covering biotechnology. Her research coverage is expected to include SMID cap biotech companies across the therapeutic space, with an initial...
David Marek Axsome Therapeutics (NASDAQ:AXSM) has appointed David Marek as chief commercial officer, effective Aug. 31. Mr. Marek joins Axsome from Amgen (NASDAQ:AMGN), where he was most recently VP and general manager...
Steve Forte Profound Medical (TSX:PRN; OTCQX:PRFMF) appointed seasoned cross-border finance leader, Steve Forte, as a director and member of the board’s audit committee. Most recently, Mr. Forte was CFO of Clementia...